Action on Hearing Loss Logo
    Total results:
    Search
      Total results:

      Research is key to NHS helping people with hearing loss

      By: Dr Ralph Holme | 29 June 2018

      The NHS is helping people with hearing loss, deafness and tinnitus every day. It provides state of the art hearing aids and cutting edge cochlear implants, it offers diagnostic tests able to identify babies with a hearing loss in the first few days of life and pinpoint the genetic cause of some types of hearing loss.

      These benefits are the result of research much of which is funded by charities such as Action on Hearing Loss where I lead its biomedical research work. Action on Hearing Loss runs the world’s largest donor-supported hearing research programme, funding medical breakthroughs for 20 years. We are proud to work hand in hand with the NHS and here are just a few examples of how over the years our research has helped the NHS transform the lives of people with hearing loss.

      We played a key role in the development of the Oto-Acoustic Emissions (OAE) test, which enables babies with a hearing loss to be identified at birth. This is important as it ensures that deaf children get the help they need straight away. The test was developed following the discovery that healthy ears produce an ‘echo’ in response to incoming sounds. Because the test can be performed quickly and easily using a tiny probe in the ear, it is a great screening tool suitable for new-born babies – they don’t even need to be awake! We supported the original laboratory research at the MRC Institute of Hearing Research and the University of Southampton in the early 1990s. We also funded the clinical studies that led to the development of this technology and the publication of the guidelines for hospitals to use the test. The test has now been introduced throughout the NHS ensuring that deaf children receive the support they need.

      Another test that we helped develop is the genetic test to identify some of the causes of deafness. Most people do not know why they or their child have a hearing loss. For some it may not matter, but many do want to know the cause. Parents of a deaf child may want to know if they are likely to have more deaf children, or whether their child’s hearing loss will get worse over time or is part of a syndrome like Usher’s syndrome. As new treatments emerge, understanding the exact cause of someone’s hearing loss will allow the right treatment to be given to the right person.

      Any one of over 100 genes can cause hearing loss. Testing all of these genes to make an accurate diagnosis used to be prohibitively time consuming and expensive. In practice only one or two of the more common genes would be tested in the clinic. But that has now all changed thanks to research we funded at the University of Antwerp and UCL’s Institute of Child Health. We helped develop a new way of testing deafness genes that now allows 95 genes to be tested all at the same time and for the same price as it used to cost to test just one or two genes using the old technology. The new genetic test is now available through the NHS benefiting people across the country.

      But what does the future of hearing research hold? We continue to fund research around the world to accelerate the development of new treatments for all types of hearing loss. Amazing progress is being made. There are already drug treatments being clinically tested that we hope will be able to reduce hearing loss caused by the damaging effects of noise and the ototoxic side effects of some life-saving medication, such as cisplatin, used to treat cancer, and aminoglycosides, used to fight serious bacterial infections. Drug and gene therapies to trigger the regeneration of the sound-detecting sensory cells within the cochlea are also being clinically tested. One of these clinical trials is currently taking place at the Royal National Throat Nose and Ear Hospital (UCLH NHS Foundation Trust) in London. Scientists we are funding continue to make discoveries that we hope will lead to treatments for other types of hearing loss such as age-related hearing loss and of course tinnitus.

      Over the last 70 years the options available to the NHS to treat hearing loss have largely been limited to hearing aids and cochlear implants. We are now entering a new exciting era in which we will see the NHS start using drug, gene and cell therapies to more effectively treat hearing loss and tinnitus. Our research projects are funded by donations and thanks to your support we hope that many more people will be able to benefit from our scientific discoveries.

      We depend on your donations so we can fund the best hearing and tinnitus research around the world. Donate today and help us continue our vital work into hearing treatments, so that people can live life to the full again.

      Ralph Holmes

      Recent Posts

      International Symposium on Inner Ear Therapeutics

      Earlier this month Action on Hearing Loss joined scientists, pharmaceutical companies and clinicians from around the world in Hanover, Germany, to discuss the latest developments in treatments for inner ear-related diseases, including hearing loss and tinnitus.

      By: Cláudia Gonçalves
      19 November 2019

      Tech ideas to help raise awareness of hearing loss

      For the last couple of years, Microsoft UK has hosted an Ideas Generator event for charities. It’s a chance to explore how charities can harness the latest technology to provide real-world solutions. This year, the Microsoft team chose Action on Hearing Loss to attend along with four other charities.

      By: Kevin Taylor
      14 November 2019

      How Akouos Therapeutics is working to develop genetic therapies for hearing loss

      Ακούω is a Greek word that means to listen. Akouos Therapeutics (pronounced ah KOO ohs) is a biotechnology company based in Boston, USA. It was formed in 2016 with the goal of applying precision genetic medicine to conditions that cause hearing loss. A key step in the development of such treatments underlies the choice of the company’s name.

      By: Jim McLaughlin, Akouos Therapeutics
      14 November 2019

      Hearing Health by Apple

      Hearing loss caused by excessively loud music and audio from personal listening devices is an increasing problem. In the latest version of their Health app, Apple are introducing new features to tackle the issue. They will be available as part of their iOS13.1 software update.

      By: Jesal Vishnuram
      11 October 2019

      Recent Posts

      International Symposium on Inner Ear Therapeutics

      Earlier this month Action on Hearing Loss joined scientists, pharmaceutical companies and clinicians from around the world in Hanover, Germany, to discuss the latest developments in treatments for inner ear-related diseases, including hearing loss and tinnitus.

      By: Cláudia Gonçalves
      19 November 2019

      Tech ideas to help raise awareness of hearing loss

      For the last couple of years, Microsoft UK has hosted an Ideas Generator event for charities. It’s a chance to explore how charities can harness the latest technology to provide real-world solutions. This year, the Microsoft team chose Action on Hearing Loss to attend along with four other charities.

      By: Kevin Taylor
      14 November 2019

      How Akouos Therapeutics is working to develop genetic therapies for hearing loss

      Ακούω is a Greek word that means to listen. Akouos Therapeutics (pronounced ah KOO ohs) is a biotechnology company based in Boston, USA. It was formed in 2016 with the goal of applying precision genetic medicine to conditions that cause hearing loss. A key step in the development of such treatments underlies the choice of the company’s name.

      By: Jim McLaughlin, Akouos Therapeutics
      14 November 2019

      Hearing Health by Apple

      Hearing loss caused by excessively loud music and audio from personal listening devices is an increasing problem. In the latest version of their Health app, Apple are introducing new features to tackle the issue. They will be available as part of their iOS13.1 software update.

      By: Jesal Vishnuram
      11 October 2019

      More like this

      We're really proud of everyone who's a part of Action on Hearing Loss, and hope you'll feel inspired to become a part of our community.​

      We campaign for changes that make life better for people who are confronting deafness, tinnitus and hearing loss.

      Our ears are our organs of hearing and balance. They have three parts: the outer, middle and inner ear.